Kernodle & Katon Asset Management Group’s Omega Protein OME Stock Holding History

Kernodle & Katon Asset Management Group’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$1K	Buy	+32	New	+$745	﹤0.01%	325

Other funds holding OME

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

JIR

James Investment Research Alpha, Ohio $891M AUM 30.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Kernodle & Katon Asset Management Group's OME Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group opened a new position in Omega Protein (OME) in Q1 2017: 32 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #325 among its holdings.

144 funds tracked by Wall St. Rank hold OME as of Q1 2017.

Kernodle & Katon Asset Management Group held 32 shares of Omega Protein worth $1K as of Q1 2017.
Omega Protein was a new Kernodle & Katon Asset Management Group position in Q1 2017.
Omega Protein made up ﹤0.01% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #325 holding.
144 funds tracked by Wall St. Rank held Omega Protein as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.